Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of the "Treat-and-extend" Scheme in Patients With Retinal Vein Occlusion (PEARL)
NCT02522897Phase 4Unknown
- Start
- Aug 2015
- Primary completion
- Jan 2018
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
01
Overview
A Phase 4 trial of ranibizumab in central retinal vein occlusion (CRVO), macular edema. Status: unknown.
02
Drugs
ranibizumab
03
Conditions
central retinal vein occlusion (CRVO)macular edema
Beyond the preview
Go deeper on NCT02522897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02522897.